Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
1.31
0.08 (6.50%)
At close: May 23, 2025, 3:59 PM
1.31
-0.38%
After-hours: May 23, 2025, 05:49 PM EDT
6.50% (1D)
| Bid | 1.2 |
| Market Cap | 241.82M |
| Revenue (ttm) | 396.59K |
| Net Income (ttm) | -35.36M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -5.98 |
| Forward PE | -5.35 |
| Analyst | Buy |
| Ask | 1.38 |
| Volume | 1,290,252 |
| Avg. Volume (20D) | 882,538 |
| Open | 1.20 |
| Previous Close | 1.23 |
| Day's Range | 1.19 - 1.40 |
| 52-Week Range | 0.26 - 3.09 |
| Beta | -0.80 |
About TVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+7.74%
Tevogen Bio Holdings shares are trading higher aft...
Unlock content with
Pro Subscription
3 weeks ago
-5.52%
Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.
